Sotagliflozin: first global approval
Hair Growth & Follicular Health Recent investigations indicate that GHK-Cu: Activates dermal papilla cells, the specialized cells at the base of hair follicles controlling growth phase (anagen) entry Reduces follicle sensitivity to DHT (dihydrotestosterone), the hormone primarily responsible for androgenetic alopecia Promotes angiogenesis to the scalp, increasing oxygen and nutrient delivery to follicles Suppresses inflammatory cytokines that contribute to follicle miniaturization Enhances hair density and thickness through collagen synthesis and follicular cell proliferation Safety Considerations The safety profile is well documented
The most responsible posture is proactive: Define the Zepbound and NAION risk clearly
If food noise remains an issue or returns, strategies include: Mindfulness techniques: Acknowledging thoughts about food without judgment and letting them pass (e.g., the "conveyor belt" technique where thoughts are visualized as boxes passing by)
[ref open access] Why could the risk be greater during infancy
Program rules could prove challenging To get medications covered under the new program, providers must submit a prior authorization request and a prescription for an eligible GLP-1 drug for an approved use